NACA attributes progress to ending HIV/AIDS to media interventions
By Justina Auta
Dr Temitope Ilori, the Director-General, National Agency for the Control of AIDS (NACA)
has attributed the significant progress made in ending HIV/AIDS in Nigeria to journalists amplifying issues around the
epidemic on their media spaces.
Ilori stated this during the end of year media party organised by NACA to celebrate the progress, impact and partnership with journalists in Abuja.
According to her, amplifying issues around HIV has further raised awareness on prevention, care and treatment, geared toward meeting the 2030
target of eliminating AIDS in Nigeria.
She said “the gospel of HIV is all about the media. It is all about prevention, care and treatment. But the news and information has to be out there.
“We appreciate journalists who collaborated with us in our vision, mission and goal of achieving an AIDS-free generation and making sure AIDS
is no longer a public health threat by 2030.”
She also noted the pivotal role journalists play in creating awareness on Prevention-of Mother-to-Child Transmission of HIV (PMTCT), advocacies
for policies to protect the vulnerable, especially children.
“We also launched the PMTCT acceleration plan, which you have done a good work in projecting it, aimed at addressing gaps in testing and prevention
of HIV to achieve zero transmission to newborns,” she said.
She revealed that Nigeria has HIV prevalence of 1.4 per cent among general population, 15-64 years, with an estimated two million people living with the virus.
The NACA boss, while urging the media to sustain the fight against HIV/AIDS by amplifying issues around the epidemic, encouraged stakeholders and the
public to renew commitment to ending the epidemic, especially among children.
Also, Mrs Toyin Aderibigbe, the Deputy Director, Public Relations and Protocol Division, NACA, commended the media for their commitments toward
ending AIDS in Nigeria and urged them to sustain the fight.
She added that “your support and commitment to amplifying the stories, campaigns and programmes on HIV response in Nigeria has been instrumental
in advancing our mission to combat HIV/AIDS and improve public health.
“The milestones we celebrate today would not have been possible without your impactful reporting and dedication.”
Other events of the day were the conferment of awards to notable journalists like Justina Auta of the News Agency of Nigeria (NAN); Lara Adejoro,
The Punch Newspaper; Nike Adebowale-Tambe, Premium Times, among others.
The journalists were conferred with various awards for their exceptional reporting on HIV-related issues.
Mrs Bassey Ita-Ikpang, the FCT Chairperson of Nigeria Association of Women Journalists (NAWOJ), who spoke on behalf of the award recipients,
thanked the Federal Government for the recognition.
Ita-Ikpang assured the commitment of the award recipients and other journalists to sustain the fight against HIV/AIDS.
She said “we will keep on reporting and amplifying the messages of NACA and other stakeholders in ending AIDS in Nigeria.”
She urged other stakeholders to continue to collaborate toward ending stigma, discrimination and reducing new infections in the country.
It will be recalled that Dr Iziaq Adekunle-Salako, the Minister of State for Health and Social Welfare, had noted Nigeria’s significant progress in
the fight against HIV/AIDS, with a current prevalence rate of 1.4 per cent in the general population and an estimated two million people living with HIV.
Also, Dr Leo Zekeng, the UNAIDS Country Representative, said Nigeria had achieved notable progress in treatment access, with 1.6 million out of two
million people living with HIV currently on treatment.
Zekeng, however, said that challenges such as stigma, discrimination and access to prevention and treatment services remained.
He said “as of 2023, approximately two million people are living with HIV in the country, with an adult prevalence rate of 1.3 per cent among
individuals aged 15–49. Nigeria recorded approximately 130,000 new HIV infections in 2010.
“By 2023, the number declined to about 75,000 new infections, representing a reduction of approximately 55,000 cases, or a 42.3 per cent decrease over 13 years.
“The country has also achieved notable progress in treatment access, with 1.6 million out of the two million people living with HIV in Nigeria currently on treatment”. (NAN) (www.nannews.ng.com)
Edited by Hadiza Mohammed-Aliyu
FG hosts candlelight memorial for HIV/AIDS victims
By Justina Auta
The Federal Government, in partnership with stakeholders, hosted a candlelight memorial to honour those lost to HIV/AIDS-related causes.
Dr Temitope Ilori, Director-General of the National Agency for the Control of AIDS (NACA), on Monday stated that the event aimed to raise awareness about the Prevention of Mother-to-Child Transmission of HIV (PMTCT).
It is targeted at strengthening community and national dedication to eradicating AIDS.
“We want to ensure a generation free of HIV and achieve the global target of ending HIV as an epidemic by 2030.
“This gathering is both a commemoration and a tribute to those we’ve lost in the battle against HIV,” she said.
Ilori expressed concern over the estimated 15,000 children who died from AIDS-related illnesses in 2023, calling the figure alarming.
“This is deeply troubling, but together, we can reverse this trend and create a brighter future”.
She stressed the importance of ending stigma against people living with HIV, urging them to access care, adhere to treatment, and continue medication to suppress their viral load.
She also reaffirmed the government’s commitment to ending the epidemic, noting increased domestic resource mobilisation and funding for HIV/AIDS programmes.
Mr Abdulkadir Ibrahim, National Coordinator of the Network of People Living with HIV in Nigeria (NEPWHAN), noted the need to celebrate individuals and organisations dedicated to combating the epidemic.
Represented by Nicholas Ugbenyen, NEPWHAN’s National Secretary, Ibrahim advocated for policy changes, increased funding, and innovative approaches to eliminate HIV in children and end AIDS by 2030.
“We call on all stakeholders to support policies and funding that prioritise prevention and treatment of HIV in children.
“Sustainable practices, community advocacy, and grassroots engagement are essential to addressing the epidemic and ensuring children’s voices are heard”.
He further emphasised the need for accessible PMTCT services, including antenatal care, testing, and treatment for pregnant women living with HIV, to prevent the transmission of the virus to their children.
Dr Esther Hindi, National Coordinator of the Association of Women Living with HIV/AIDS in Nigeria (ASHWAN), pledged to continue raising awareness about PMTCT efforts across the country.
Other stakeholders, including Ms Funmi Adesanya from the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and Dr Leo Zekeng, UNAIDS Country Director, also reaffirmed their commitment to supporting Nigeria’s fight to end AIDS. (NAN) www.nannews.ng
Edited by Abienwense Moru
Nigeria, 7 others begin African-led HIV vaccine initiative
By Justina Auta
Nigeria and seven African countries have commenced a vaccine initiative aimed at addressing the burden of HIV infections on the continent.
The initiative, titled ‘Bringing Innovation to Clinical and Laboratory Research to End HIV in Africa through New Vaccine Technology (BRILLIANT)’, is focused on HIV vaccine research and development.
Prof. Alash’le Abimiku, Executive Director of the International Research Centre of Excellence at the Institute of Human Virology (IHVN), announced this at a press briefing on Thursday in Abuja.
The theme of the briefing was ‘HIV Vaccine, Innovation, Science, and Technology Acceleration in Africa (HIV-VISTA) Study’.
Abimiku identified the participating countries as Nigeria, South Africa, Zambia, Zimbabwe, Tanzania, Uganda, Kenya, and Mozambique.
The consortium’s objective is to evaluate HIV vaccine candidates developed within Africa.
She explained that the initiative seeks to empower African scientists to contribute to an effective HIV vaccine.
“Through these efforts, African institutions will be encouraged to become more autonomous, generate domestic resources, and form partnerships with the private sector.
“This may create a more sustainable system for HIV vaccine research and development, reducing the current reliance on U.S. government support,” she said.
Abimiku expressed optimism that the partnership would highlight Africa’s potential for innovative solutions to global health challenges, particularly those disproportionately affecting the continent.
Dr Temitope Ilori, Director-General of the National Agency for the Control of AIDS (NACA), said in spite extensive efforts, HIV continues to persist, hence the need for new preventive tools.
“The agency has consistently provided preventive measures, but an effective vaccine is crucial to our efforts.
“The HIV-VISTA study offers hope for a vaccine tailored to the needs of our population, and Nigeria’s involvement in this global initiative is essential.
“Our participation supports both local and international efforts to end AIDS, bringing us closer to a vaccine that could save countless lives across Africa and beyond,” she said.
Dr Ezekiel James, Deputy Director of the Office of HIV/TB at USAID, stated that the study creates an opportunity for stakeholders to collaborate in the drive toward HIV epidemic control.
Dr Leo Zekeng, UNAIDS Country Director, underscored the importance of engaging communities to raise awareness about HIV vaccines and ongoing research aimed at reducing HIV transmission rates.
The World Health Organisation (WHO) had on Tuesday named HIV, malaria, Tuberculosis, and 14 other pathogens as top priorities for new vaccine development.
UNAIDS reports that an estimated 39.9 million people were living with HIV globally in 2023, with about 1.3 million new infections.
Africa bears approximately 65 per cent of this burden, with Nigeria accounting for 1.9 million cases, making it the fourth-largest contributor to the global HIV burden.
The U.S. Agency for International Development (USAID) awarded over $45 million to the BRILLIANT consortium through a competitive process to implement a cooperative agreement under the HIV-VISTA project. (NAN) www.nannews.ng.com
Edited by Kadiri Abdulrahman
FG, Chinese firm partner on local HIV test kits
By Justina Auta
The Federal Government has signed a Memorandum of Understanding (MoU) with WONDFO BIOTECH Ltd. to support local production of HIV diagnostic kits in Nigeria.
Dr Temitope Ilori, Director General, National Agency for the Control of AIDS (NACA), announced this in Abuja while receiving 4,000 HIV test kits from WONDFO ahead of World AIDS Day.
“The WONDFO community recently in China signed a MoU with feedback on unlocking the value chain initiative of President Tinubu, to ensure that we have domestic production of the reagent of the test kits and other HIV commodities.
“I want to commend you for that initiative and we look forward to having your own domestic plants here in Nigeria”.
She expressed appreciation to the organisation for the commodities received, adding that the initiative would support in ending AIDS epidemic in the country.
“This will ensure that individuals can actually test for HIV, even in the comfort of their homes.
“We are happy to have this kit with us, and we want to assure you that we’re going to give it judicious use,” she added.
Earlier, Mr Bravo Ouhabru, Country Representative, WONDFO, said the test kits, comprising of both self-test and professional use tests, would enhance healthcare and support HIV prevention efforts.
He added that the initiative was part of activities to support NACA commemorate the 2024 World AIDS Day, to promote reliable testing, enable people know their status and ending the epidemic by 2030.
“A lot of people are going around not knowing that they are even carrying the virus.
“The fact that someone tested negative today does not mean that it’s negative forever.
“So it is very important we continue to move ahead with all this activity that will make everybody to be aware, to know their status.
“HIV status is very important. That is the starting point. Once you know that, then all other areas involved in HIV management can easily come in,” he said.
He said that private pharmacies would also be supplied some at a subsidised rate to enable people carry out the test in the comfort of their homes and seek medical care if reactive. (NAN) www.nannews.ng.com
Edited by Abiemwense Moru